The success of RNA vaccines in combating COVID-19 has opened up new possibilities for their use against other infectious diseases, such as influenza, Zika virus, and even certain types of cancer. Ongoing research and development aim to improve their stability, ease of distribution, and broaden their application. Additionally, advancements in mRNA technology could lead to personalized vaccines tailored to individual genetic profiles, enhancing their effectiveness and safety.
